258 related articles for article (PubMed ID: 9328168)
1. Mechanism of action of dietary chemoprotective agents in rat liver: induction of phase I and II drug metabolizing enzymes and aflatoxin B1 metabolism.
Manson MM; Ball HW; Barrett MC; Clark HL; Judah DJ; Williamson G; Neal GE
Carcinogenesis; 1997 Sep; 18(9):1729-38. PubMed ID: 9328168
[TBL] [Abstract][Full Text] [Related]
2. Regulation of aflatoxin B1-metabolizing aldehyde reductase and glutathione S-transferase by chemoprotectors.
McLellan LI; Judah DJ; Neal GE; Hayes JD
Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):117-24. PubMed ID: 8198522
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of aflatoxin B1 hepatocarcinogenesis by coumarin, a natural benzopyrone that is a potent inducer of aflatoxin B1-aldehyde reductase, the glutathione S-transferase A5 and P1 subunits, and NAD(P)H:quinone oxidoreductase in rat liver.
Kelly VP; Ellis EM; Manson MM; Chanas SA; Moffat GJ; McLeod R; Judah DJ; Neal GE; Hayes JD
Cancer Res; 2000 Feb; 60(4):957-69. PubMed ID: 10706111
[TBL] [Abstract][Full Text] [Related]
4. Regulation of glutathione S-transferases and aldehyde reductase by chemoprotectors: studies of mechanisms responsible for inducible resistance to aflatoxin B1.
Hayes JD; McLeod R; Ellis EM; Pulford DJ; Ireland LS; McLellan LI; Judah DJ; Manson MM; Neal GE
IARC Sci Publ; 1996; (139):175-87. PubMed ID: 8923030
[TBL] [Abstract][Full Text] [Related]
5. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
Stresser DM; Bailey GS; Williams DE
Drug Metab Dispos; 1994; 22(3):383-91. PubMed ID: 8070314
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver--predicting the outcome using early biomarkers.
Manson MM; Hudson EA; Ball HW; Barrett MC; Clark HL; Judah DJ; Verschoyle RD; Neal GE
Carcinogenesis; 1998 Oct; 19(10):1829-36. PubMed ID: 9806166
[TBL] [Abstract][Full Text] [Related]
7. Induction of phase I and phase II drug-metabolizing enzyme mRNA, protein, and activity by BHA, ethoxyquin, and oltipraz.
Buetler TM; Gallagher EP; Wang C; Stahl DL; Hayes JD; Eaton DL
Toxicol Appl Pharmacol; 1995 Nov; 135(1):45-57. PubMed ID: 7482539
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of aflatoxin Ml excretion in rat urine during dietary intervention with oltipraz.
Scholl P; Musser SM; Kensler TW; Groopman JD
Carcinogenesis; 1996 Jun; 17(6):1385-8. PubMed ID: 8681461
[TBL] [Abstract][Full Text] [Related]
9. Ethoxyquin-induced resistance to aflatoxin B1 in the rat is associated with the expression of a novel alpha-class glutathione S-transferase subunit, Yc2, which possesses high catalytic activity for aflatoxin B1-8,9-epoxide.
Hayes JD; Judah DJ; McLellan LI; Kerr LA; Peacock SD; Neal GE
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):385-98. PubMed ID: 1953636
[TBL] [Abstract][Full Text] [Related]
10. Potent inhibition of aflatoxin-induced hepatic tumorigenesis by the monofunctional enzyme inducer 1,2-dithiole-3-thione.
Kensler TW; Groopman JD; Eaton DL; Curphey TJ; Roebuck BD
Carcinogenesis; 1992 Jan; 13(1):95-100. PubMed ID: 1346373
[TBL] [Abstract][Full Text] [Related]
11. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes.
Ahn D; Putt D; Kresty L; Stoner GD; Fromm D; Hollenberg PF
Carcinogenesis; 1996 Apr; 17(4):821-8. PubMed ID: 8625497
[TBL] [Abstract][Full Text] [Related]
12. Modulation of aflatoxin metabolism, aflatoxin-N7-guanine formation, and hepatic tumorigenesis in rats fed ethoxyquin: role of induction of glutathione S-transferases.
Kensler TW; Egner PA; Davidson NE; Roebuck BD; Pikul A; Groopman JD
Cancer Res; 1986 Aug; 46(8):3924-31. PubMed ID: 2873884
[TBL] [Abstract][Full Text] [Related]
13. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
Buetler TM; Bammler TK; Hayes JD; Eaton DL
Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
[TBL] [Abstract][Full Text] [Related]
14. The model Ah-receptor agonist beta-naphthoflavone inhibits aflatoxin B1-DNA binding in vivo in rainbow trout at dietary levels that do not induce CYP1A enzymes.
Takahashi N; Harttig U; Williams DE; Bailey GS
Carcinogenesis; 1996 Jan; 17(1):79-87. PubMed ID: 8565141
[TBL] [Abstract][Full Text] [Related]
15. Indole-3-carbinol induces a rat liver glutathione transferase subunit (Yc2) with high activity toward aflatoxin B1 exo-epoxide. Association with reduced levels of hepatic aflatoxin-DNA adducts in vivo.
Stresser DM; Williams DE; McLellan LI; Harris TM; Bailey GS
Drug Metab Dispos; 1994; 22(3):392-9. PubMed ID: 8070315
[TBL] [Abstract][Full Text] [Related]
16. Regulation of rat glutathione S-transferase A5 by cancer chemopreventive agents: mechanisms of inducible resistance to aflatoxin B1.
Hayes JD; Pulford DJ; Ellis EM; McLeod R; James RF; Seidegård J; Mosialou E; Jernström B; Neal GE
Chem Biol Interact; 1998 Apr; 111-112():51-67. PubMed ID: 9679543
[TBL] [Abstract][Full Text] [Related]
17. Effects of dietary oltipraz and ethoxyquin on aflatoxin B1 biotransformation in non-human primates.
Bammler TK; Slone DH; Eaton DL
Toxicol Sci; 2000 Mar; 54(1):30-41. PubMed ID: 10746929
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of protection against aflatoxin tumorigenicity in rats fed 5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione (oltipraz) and related 1,2-dithiol-3-thiones and 1,2-dithiol-3-ones.
Kensler TW; Egner PA; Dolan PM; Groopman JD; Roebuck BD
Cancer Res; 1987 Aug; 47(16):4271-7. PubMed ID: 2886217
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effect of low- and high-dose dietary butylated hydroxytoluene on microsome-mediated aflatoxin B1-DNA binding.
Allameh A
Cancer Lett; 1997 Mar; 114(1-2):217-20. PubMed ID: 9103296
[TBL] [Abstract][Full Text] [Related]
20. Metabolic basis for the protective effect of the antioxidant ethoxyquin on aflatoxin B1 hepatocarcinogenesis in the rat.
Mandel HG; Manson MM; Judah DJ; Simpson JL; Green JA; Forrester LM; Wolf CR; Neal GE
Cancer Res; 1987 Oct; 47(19):5218-23. PubMed ID: 2887284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
